Z. Reguiaï

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa

Alexa B. Kimball, Martin M. Okun, David Williams et al. · New England Journal of Medicine · 2016 · 777 citations

Medicine, Dermatology, Pharmacology +16

Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

Alexa B. Kimball, Gregor B. E. Jemec, Afsáneh Alavi et al. · The Lancet · 2023 · 302 citations

Life Sciences, Immunology, Pharmacotherapy +6

Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort

Sarah Faiz, Jonathan Giovannelli, Céline Podevin et al. · Journal of the American Academy of Dermatology · 2019 · 207 citations · Full text

Life Sciences, Dermatology, Immunology +8

Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa

Christos C. Zouboulis, Hendrik H.G. Hansen, Giovanni Damiani et al. · Dermatology · 2019 · 69 citations

Medicine, Pharmacology, Pharmacotherapy +13

Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation

J. Sanchez, Sébastien Le Jan, C. Muller et al. · Experimental Dermatology · 2019 · 60 citations

Medicine, Dermatology, Pathology +15